Epilepsy: Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children age 3 years and above. Safety and effectiveness for adjunctive therapy in pediatric patients below the age of 3 years have not been established.
Neuropathic Pain: Gabapentin is indicated for the treatment of neuropathic pain in adults age 18 years and above.
Safety and effectiveness in patients below the age 18 years have not been established.